se of certain Immunological Markers in blood to detect infection in Neonates.
Not Applicable
- Conditions
- Health Condition 1: null- Neonatal Sepsis
- Registration Number
- CTRI/2012/05/002651
- Lead Sponsor
- BECTION DICKINSON AND COMPANY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Term or Pre-term neonates (born at greater than 28 weeks gestation) admitted to neonatal intensive care units, presenting with signs and symptoms suggestive of systemic infection and requiring a full sepsis evaluation and antibiotic treatment will be eligible for inclusion in the study irrespective of their birth weight and postnatal age.
Exclusion Criteria
Patients who were already receiving parenteral antibiotics at time of initial sepsis evaluation will be excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method